Qatar bans dextropropoxyphene and all products containing it, touting it as a harmful drug holding substantial side-effects. Growing concerns has led Qatar to remove all medical products containing dextropropoxyphene from its shelves.Primarily, dextropropoxyphene is used as a pain-reliever, but can led to considerable side effects, such as headaches; drowsiness; mood swings; skin allergies; hallucinations; dizziness; nausea; vomiting; and gastric issues, such as constipation. So much so, it is also labeled as addictive!
An overdose of the same can led to detrimental health hazards, such as hypo-tension; convulsions; coma; drowsiness; respiratory depression; and circulatory collapse, as mentioned in the various reports issued about the drug.
The Supreme Council of Health (SCH) in Qatar has ordained all the pharmacies and hospitals in the country to retract all medical products and drugs which may contain the substance, whether or not it is mixed with other products.
"The SCH is keen to ensure the quality, safety and efficacy of medicines sold in the country,” said Dr Aisha Al Ansari, the Director of the Pharmacy and Drug Control Department at the SCH.
Considering the health hazards that dextropropoxyphene could create, several developed countries have banned the product and continue to do so.
New Zealand health officials withdrew two painkillers containing dextropropoxyphene this year, as they concluded that the possible risks of such pain-relievers could outweigh the benefits. It was told that Paradex and Capadex tablets were as good at relieving pain as a full-dose of paracetamol, but caused more harmful side-effects if consumed with alcohol or in an overdose.
In the United Kingdom, medicines containing only dextropropoxyphene were discontinued in 2004.
Comments
Post a Comment